Pharmafile Logo
Pharmafocus logo
Advanced Search

Truvada

Showing 13 posts of 13 posts found.

truvada-web

Gilead’s Truvada becomes first China-approved drug to prevent HIV-1

August 13, 2020
Sales and Marketing China, Truvada, approval. HIV

China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …

News
gilead-sciences

Gilead challenges Government over patents on preventative HIV drug Truvada

August 22, 2019
Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents

Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …

News
46438135835_a0bd733416_z

Gilead CEO Daniel O’Day challenged over patents on PrEP drug Truvada

May 17, 2019
Medical Communications Gilead, HIV, PrEP, Truvada, patent, pharma

On 16 May, Gilead CEO Daniel O’Day was grilled over the $1,780 price tag on PrEP drug Truvada in a …

News
32514377531_3583dbc34b_z

Gilead will give 11 years’ worth of PrEP drugs to those at risk of HIV after ‘discussions’ with Trump

May 10, 2019
Medical Communications Gilead, HIV, PrEP, Trump, Truvada, descovy

Gilead Sciences has agreed to donate 11 years’ worth PrEP drugs for up to 200,000 individuals each year, following “discussions …

News

Gilead accused of ripping off US taxpayers

March 28, 2019
Medical Communications, Sales and Marketing CDC, Gilead, HIV, PrEP, Truvada, US government, patents

Gilead have been accused of ‘ripping off’ US taxpayers after the firm was revealed to have generated $3 billion in …

News
truvada-web

AIDS charity lambasts “ethically challenged” Gilead over price hikes

January 11, 2018
Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical

The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …

News

Anti-HIV drug PrEP proves safety in gay and bisexual adolescents

September 6, 2017
Research and Development Gilead, HIV, Pharamceuticals, PrEP, Truvada, health, medicine, pharma

A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects …

News

HIV-preventing drug to be trialed across England

August 7, 2017
Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical

NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …

News
gilead-sciences

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017
Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …

News
nhs_trees

Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court

A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …

News
gilead-sciences

Gilead gets EU approval for HIV-prevention treatment Truvada

August 23, 2016
Manufacturing and Production, Sales and Marketing EU, Gilead, HIV, PrEP, Truvada, prevention

Gilead Sciences has received marketing authorisation from the European Commission for once-daily Truvada (emtricitabine/tenofovir disoproxil), in combination with safer sex …

News
Truvada pill

Gilead’s Truvada prevents HIV infections in high-risk men

September 10, 2015
Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections

UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …

News

Triple regimen HIV pill gains approval

August 11, 2011
Gilead, HIV, J&J, JJ, Truvada

A new three-in-one pill Complera has been approved in the US as a first line treatment for HIV. Complera combines …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024